The silent epidemic of thiazide-induced hyponatremia

Journal of Clinical Hypertension

Volumn 10, Issue 6, 2008, Pages 477-484

  Mann, Samuel J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROPAMIDE; CHLORTALIDONE; EPLERENONE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM SPARING DIURETIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TOLVAPTAN; TORASEMIDE; TRIAMTERENE; VASOPRESSIN;

BLOOD PRESSURE REGULATION; BRAIN EDEMA; CARDIOVASCULAR DISEASE; CENTRAL PONTINE MYELINOLYSIS; CLINICAL PROTOCOL; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DIURESIS; DOSE RESPONSE; DRUG ABSORPTION; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENCY; DRUG POTENTIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELDERLY CARE; EMERGENCY CARE; EPIDEMIC; FLUID INTAKE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LONG TERM CARE; LOW DRUG DOSE; PATHOPHYSIOLOGY; PATIENT MONITORING; POLYDIPSIA; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; RISK FACTOR; SINGLE DRUG DOSE; SODIUM BLOOD LEVEL; SODIUM INTAKE; THIAZIDE INDUCED HYPONATREMIA; WATER DEPRIVATION; AGE; CHEMICALLY INDUCED DISORDER;

AGE FACTORS; HUMANS; HYPONATREMIA; RISK FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 55249094890     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.08126.x     Document Type: Review

References (34)

1. Ashouri OS. Severe diuretic-induced hyponatremia in the elderly. Aseries of eight patients. Arch Intern Med. 1986;146:1355-1357.
2. Clayton JA, Rodgers S, Blakey J, et al. Thiazide diuretic prescription and electrolyte abnormality in primary care. Br J Clin Pharmacol. 2006;61:87-95.
3. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest. 1993;103:601-606.
4. Chow KM, Szeto CC, Wong TY, et al. Risk factors for thiazide-induced hyponatraemia. QJM. 2003;96:911-917.
5. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255-3264.
6. Sunderam SG, Mankikar GD. Hyponatraemia in the elderly. Age Ageing. 1983;12:77-80.
7. Sharabi Y, Illan R, Kamari Y, et al. Diuretic induced hyponatraemia in elderly hypertensive women. J Hum Hypertens. 2002;16:631-635.
8. Sonnenblick M, Algur N, Rosin A. Thiazide-induced hyponatremia and vasopressin release. Ann Intern Med. 1989;110(9):751.
9. Friedman E, Shadel M, Halkin H, et al. Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med. 1989;110:24-30.
10. Clark BA, Shannon RP, Rosa RM, et al. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol. 1994;5:1106-1111.
11. Greenberg A. Diuretic complications. Am J Med Sci. 2000;319:10-24.
12. Spital A. Diuretic-induced hyponatremia. Am J Nephrol. 1999;19:447-452.
13. Fichman MP, Vorherr H, Kleeman CR, et al. Diuretic-induced hyponatremia. Ann Intern Med. 1971;75(6):853-863.
14. Tarssanen L, Huikko M, Rossi M. Amiloride-induced hyponatremia. Acta Med Scand. 1980; 208: 491-494.
15. Strykers PH, Stern RS, Morse BM. Hyponatremia induced by a combination of amiloride and hydrochlorothiazide. JAMA. 1984;252:389.
16. Brater DC. Diuretic therapy. N Engl J Med. 1998;339:387-395.
17. Szatalowicz VL, Illan R, Kamari Y, et al. Comparative effect of diuretics on renal water excretion in hyponatraemic oedematous disorders. Clin Sci. 1982;62:235-238.
18. Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med. 1986;81:1033-1040.
19. Kumar S, Berl T. Sodium. Lancet. 1998;352(9123):220-228.
20. Sonnenblick M, Rosin AJ. Significance of the measurement of uric acid fractional clearance in diuretic induced hyponatraemia. Postgrad Med J. 1986;62:449-452.
21. Walker RM, Brown RS, Stoff JS. Role of renal prostaglandins during antidiuresis and water diuresis in man. Kidney Int. 1982;21:365-370.
22. Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med. 1981;70:1163-1168.
23. Sterns RH, Silver SM. Brain volume regulation in response to hypo-osmolality and its correction. Am J Med. 2006;119(7A):S12-S16.
24. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342:1581-1589.
25. Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: Correlation with brain water and electrolytes. Medicine (Baltimore). 1976;55:121-129.
26. Sterns RH. The treatment of hyponatremia: First, do no harm. Am J Med. 1990;88:557-560.
27. Adrogue HJ. Consequences of inadequate management of hyponatremia. Am J Nephrol. 2005;25:240-249.
28. Hamburger S, Koprivica B, Ellerbeck E, et al. Thiazide-induced syndrome of inappropriate secretion of antidiuretic hormone. Time course of resolution. JAMA. 1981;246:1235-1236.
29. Janicic N, Verbalis JG. Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am. 2003;32:459-481.
30. Cluitmans FHM, Meinders AE. Management of severe hyponatremia: Rapid or slow correction? Am J Med. 1990;88:161-165.
31. Gheorghiade M, Niazi I, Ouyang J, et al; Tolvaptan Investigators. Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: Results from a double-blind, randomized trial. Circulation. 2003;107:2690-2696.
32. Friedel HA, Buckley MM-T. Torasemide. A review of its pharmacological properties and therapeutic potential. Drugs. 1991;41:81-103.
33. Broekhuysen J, Deger F, Douchamps J, et al. Torasemide, a new potent diuretic. Double-blind comparison with furosemide. Eur J Clin Pharmacol. 1986;31(suppl):29-34.
34. Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 2006;119(1):71.e1-71.e8.